BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9255439)

  • 1. Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression.
    Majewski S; Jabłońska S; Orth G
    Clin Dermatol; 1997; 15(3):321-34. PubMed ID: 9255439
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermodysplasia verruciformis.
    Kawashima M
    J Dermatol; 1992 Nov; 19(11):707-9. PubMed ID: 1338070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermodysplasia verruciformis associated with multiple squamous cell carcinomas.
    Salmon R; Thompson C; Rose B; Kelly G; Cossart Y
    Australas J Dermatol; 1988 Apr; 29(1):9-15. PubMed ID: 2854970
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidermodysplasia verruciformis: what's new?
    Jablonska S; Majewski S
    J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):381-2. PubMed ID: 12834445
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermodysplasia verruciformis.
    Jablonska S; Orth G
    Clin Dermatol; 1985; 3(4):83-96. PubMed ID: 2850863
    [No Abstract]   [Full Text] [Related]  

  • 6. The Clinical Implication of Incidental Epidermodysplasia Verruciformis.
    Borretta LJ; Kirchhof MG; Crawford RI
    Am J Dermatopathol; 2021 Feb; 43(2):156-158. PubMed ID: 32649343
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidermodysplasia verruciformis: immunological and clinical aspects.
    Jablonska S; Majewski S
    Curr Top Microbiol Immunol; 1994; 186():157-75. PubMed ID: 8205840
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidermodysplasia verruciformis.
    Hafeez ZH; Thawerani H
    J Pak Med Assoc; 1996 Dec; 46(12):282-4. PubMed ID: 9000832
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous squamous cell carcinoma with epidermodysplasia verruciformis-like features in a patient with Schimke immune-osseous dysplasia.
    Collins MK; Peters K; English JC; Rady P; Tyring S; Jedrych J
    J Cutan Pathol; 2018 Jun; 45(6):465-467. PubMed ID: 29498428
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of epidermodysplasia verruciformis (EV) with human papillomavirus 16 (HPV16) DNA detected in the skin lesions: can HPV16 infect patients with EV?
    Hayashi S; Hatamochi A; Soutome A; Hamasaki Y; Yamazaki S; Kawase M; Tadano M; Kitasato H
    Int J Dermatol; 2011 Sep; 50(9):1168-70. PubMed ID: 22126886
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis.
    Padlewska K; Ramoz N; Cassonnet P; Riou G; Barrois M; Majewski S; Croissant O; Jablonska S; Orth G
    J Invest Dermatol; 2001 Oct; 117(4):935-42. PubMed ID: 11676835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why epidermodysplasia verruciformis - a rare genetic disease - has raised such great interest.
    Majewski S; Jablonska S
    Int J Dermatol; 2004 Apr; 43(4):309-11. PubMed ID: 15090022
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel human papillomavirus identified in epidermodysplasia verruciformis.
    Harris AJ; Purdie K; Leigh IM; Proby C; Burge S
    Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel EVER1 gene mutation associated with epidermodysplasia verruciformis and multiple cutaneous malignancies.
    Kim NY; Cheon DU; Joh HC; Kim JE
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e524-e526. PubMed ID: 36268689
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin cancer in epidermodysplasia verruciformis patients from Brazil.
    Oliveira WR; Rady PL; Festa C; Rivitti EA; Tyring SK
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1154-6. PubMed ID: 16987289
    [No Abstract]   [Full Text] [Related]  

  • 16. Perianal warts and the development of squamous cell carcinoma in epidermodysplasia verruciformis.
    Kivanc-Altunay I; Erdogan HK; Kayaoglu S
    Indian J Dermatol Venereol Leprol; 2011; 77(1):112. PubMed ID: 21220907
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigen presentation and T-cell activation in epidermodysplasia verruciformis.
    Cooper KD; Androphy EJ; Lowy D; Katz SI
    J Invest Dermatol; 1990 Jun; 94(6):769-76. PubMed ID: 2162366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermodysplasia verruciformis.
    Dyall-Smith D; Cowen P; Varigos G
    Australas J Dermatol; 1989; 30(2):81-5. PubMed ID: 2486177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive squamous cell carcinoma in a patient with epidermodysplasia verruciformis.
    Dhillon I; Zouzias D; Geronemus R
    J Dermatol Surg Oncol; 1991 Mar; 17(3):300-2. PubMed ID: 2005254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermodysplasia verruciformis after cutaneous T-cell lymphoma: Periungual presentation.
    Cutlan JE; Rashid RM; Torres-Cabala C; Tyring SK; Thomas V
    Dermatol Online J; 2010 Aug; 16(8):12. PubMed ID: 20804689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.